je.st
news
Competition springing up for Humira, AbbVie's hot-selling drug
2015-10-14 23:38:20| Agriculture - Topix.net
Another week, and another competitor is nipping at the heels of AbbVie Inc.'s rheumatoid arthritis treatment Humira, the top-selling drug in the world. This time it's Eli Lilly and its biotech partner Incyte Corp., which on Wednesday announced that their experimental drug baricitinib proved superior to Humira in a large study, raising questions about whether AbbVie of North Chicago can protect a product that generated $12.5 billion in sales last year.
Tags: drug
competition
humira
hotselling
Category:Agriculture and Forestry